Clinical Trial

"Hypoxic vs. Aerobic Training in Chronic Kidney Disease

Study acronym: IHT-CKD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Chronic kidney disease (CKD) leads to poor exercise tolerance, vascular dysfunction, and reduced quality of life. This randomized controlled trial will compare intermittent hypoxic training (IHT) with traditional aerobic training in patients with CKD stages 3-4. A total of 60 participants aged 40-65 years will be recruited and randomized into three groups. Interventions will last 12 weeks, with three 30-minute supervised sessions per week. Outcome measures include exercise tolerance (6-Minute Walk Test), cardiovascular parameters (blood pressure, heart rate recovery), kidney function (serum creatinine, eGFR), fatigue (Fatigue Severity Scale), and quality of life (KDQOL-36)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-12; most recent amendment 2025-12-18.
Trial Details
NCT Number NCT07180875
Lead Sponsor Pharos University in Alexandria
Conditions Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD
Enrollment 60 participants
Start Date 2025-12-09
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-24